MCM
ABMD

Marsico Capital Management’s Abiomed Inc ABMD Stock Holding History

Marsico Capital Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-13,935
Closed -$2.48M – 92
2019
Q3 		$2.48M Hold
13,935
– – 0.1% 73
2019
Q2 		$3.63M Buy
13,935
+1,650
+13% +$438K 0.13% 73
2019
Q1 		$3.51M Buy
12,285
+6,342
+107% +$2.11M 0.13% 72
2018
Q4 		$1.93M Buy
5,943
+2,378
+67% +$826K 0.08% 72
2018
Q3 		$1.6M Buy
+3,565
New +$1.41M 0.05% 83

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Marsico Capital Management's ABMD Position: Q4 2019 in Review

Marsico Capital Management sold out of Abiomed Inc (ABMD) in Q4 2019, closing a stake of 13,935 shares — an estimated $2.48M sold.

Marsico Capital Management first reported a position in ABMD in Q3 2018 and held it in 5 quarters. The position peaked at $3.63M in Q2 2019. 465 funds tracked by Wall St. Rank hold ABMD as of Q4 2019.

  • Marsico Capital Management reported no remaining Abiomed Inc position as of Q4 2019 after selling out during the quarter.
  • Marsico Capital Management sold 13,935 Abiomed Inc shares in Q4 2019, an estimated $2.48M.
  • Marsico Capital Management first reported a position in Abiomed Inc in Q3 2018 and held it in 5 quarters.
  • Marsico Capital Management's Abiomed Inc position peaked at $3.63M in Q2 2019.
  • 465 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2019.

Based on Marsico Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.